PanTher Therapeutics
panthertx.com
Oncology Therapeutics
Drug Discovery
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
1-10
employees, estimated range
Backers
1
Walnut Venture Associates
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 14, 2024
Certified PanTher Therapeutics Receives FDA Clearance of IND Application for Phase 1b Study of PTM-101 for the Localized Treatment of Pancreatic Cancer · panthertx.com
Apr 5, 2024
Board appointment PanTher Therapeutics Announces Appointment of John Edwards as Executive Chair of the Board of Directors · panthertx.com
Backed byfrom the funds' portfolios and accelerator catalogs
Walnut Venture Associates News
PanTher Completes Dose Escalation Phase in Non-Metastatic Pancreatic Cancer Phase 1b Trial and Appoints Tim Clackson to the Board of Directors
Read more
Report
From research to entrepreneurship: the story of Laura Indolfi. How PanTher Therapeutics was born and the vision behind a new generation of oncological treatments.
Read more
Report
Report
PanTher Initiates Phase 1b Clinical Trial of Absorbable, Long-Lasting, High-Dose Chemotherapy Patch for Pancreatic Cancer
Read more
Report
PanTher Therapeutics Receives FDA Clearance of IND Application for Phase 1b Study of PTM-101 for the Localized Treatment of Pancreatic Cancer
Read more
Report
PanTher Therapeutics Presents Positive First-in-Human Data for PTM-101 in Pancreatic Cancer at AACR Annual Meeting
Read more
Report